Home › Compare › AGFAF vs JNJ

AGFAF vs JNJ: Dividend Comparison 2026

AGFAF yields 13333.33% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AGFAF wins by $944051876715324800.00M in total portfolio value
10 years
AGFAF
AGFAF
● Live price
13333.33%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$944051876715324800.00M
Annual income
$930,326,183,604,330,300,000,000.00
Full AGFAF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — AGFAF vs JNJ

📍 AGFAF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAGFAFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AGFAF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
AGFAF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AGFAF
Annual income on $10K today (after 15% tax)
$1,133,333.33/yr
After 10yr DRIP, annual income (after tax)
$790,777,256,063,680,700,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, AGFAF beats the other by $790,777,256,063,680,700,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AGFAF + JNJ for your $10,000?

AGFAF: 50%JNJ: 50%
100% JNJ50/50100% AGFAF
Portfolio after 10yr
$472025938357662400.00M
Annual income
$465,163,091,802,165,140,000,000.00/yr
Blended yield
98.55%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

AGFAF
No analyst data
Altman Z
-1548.6
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AGFAF buys
0
JNJ buys
0
No recent congressional trades found for AGFAF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAGFAFJNJ
Forward yield13333.33% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$944051876715324800.00M ✓$20.0K
Annual income after 10y$930,326,183,604,330,300,000,000.00 ✓$827.78
Total dividends collected$943142383073684224.00M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AGFAF vs JNJ ($10,000, DRIP)

YearAGFAF PortfolioAGFAF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$1,344,033$1,333,333.33$10,676$355.77+$1.33M → AGFAF
2$168,918,905$167,480,789.20$11,407$389.39+$168.91M → AGFAF
3$19,852,785,021$19,672,041,793.12$12,198$426.53+$19852.77M → AGFAF
4$2,182,013,981,744$2,160,771,501,770.83$13,056$467.62+$2182013.97M → AGFAF
5$224,287,824,199,531$221,953,069,239,064.90$13,987$513.12+$224287824.19M → AGFAF
6$21,561,870,489,323,890$21,321,882,517,430,390.00$14,998$563.56+$21561870489.31M → AGFAF
7$1,938,749,165,623,537,400$1,915,677,964,199,961,300.00$16,098$619.52+$1938749165623.52M → AGFAF
8$163,055,200,603,353,700,000$160,980,738,996,136,500,000.00$17,295$681.69+$163055200603353.69M → AGFAF
9$12,827,750,571,022,997,000,000$12,653,281,506,377,408,000,000.00$18,599$750.82+$12827750571022998.00M → AGFAF
10$944,051,876,715,324,800,000,000$930,326,183,604,330,300,000,000.00$20,022$827.78+$944051876715324800.00M → AGFAF

AGFAF vs JNJ: Complete Analysis 2026

AGFAF — Stock

Digicann Ventures Inc., together with its subsidiaries, operates in the cannabis industry. The company was formerly known as Agra Ventures Ltd. and changed its name to Digicann Ventures Inc. in August 2023. Digicann Ventures Inc. was incorporated in 2004 and is headquartered in Vancouver, Canada.

Full AGFAF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this AGFAF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AGFAF vs SCHDAGFAF vs JEPIAGFAF vs OAGFAF vs KOAGFAF vs MAINAGFAF vs ABBVAGFAF vs MRKAGFAF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.